Regeneron has won a patent case against Swiss pharma giant Novartis over the delivery system for its eye drug Eylea.
The US Patent Trial and Appeal Board ruled that Novartis’ pre-filled syringe for injecting its eye medication Lucentis was “unpatentable” and handed the victory to Regeneron...
